Last edition
News about Global Pharma
AstraZeneca Pharma India Plans to Sell Bengaluru Plant
AstraZeneca Pharma Indias Bengaluru facility is one of the nine global sites that support the design and conduct of clinical trials, monitoring of safety and efficacy and other regulatory management required during a products lifecycle.
Global Pharma | 20/11/2023 | By Manvi | 1129
Natixis CIB Completes Fosun Pharma Facility
Natixis Corporate & Investment Banking (Natixis CIB) has completed a €230 million (USD 249.8 million) three-year syndicated term loan facility for Fosun Industrial.
Global Pharma | 20/11/2023 | By Manvi | 244
Cytiva Transforms Protein Purification with its New Affinity Technology
Cytiva introduces the innovative Cytiva Protein Select technology, designed to streamline and accelerate recombinant protein purification.
Global Pharma | 20/11/2023 | By Manvi | 449
The Pharma Innovation Awards represent an annual recognition of new technologies and services that aim to help improve product quality, reduce risks, and enhance pharmaceutical production efficiency.
Global Pharma | 20/11/2023 | By Manvi | 793
The DSCSA final phase includes the enforcement of exchanging serialized data at the package level and kicks in on November 27, 2024.
Global Pharma | 17/11/2023 | By Manvi | 295
Mawdsleys Unveils its Expanded Third-Party Logistics Warehouse in Doncaster
The footprint of the warehouse has been doubled to 300,000 sq ft, while major green upgrades have also been made to the site.
Global Pharma | 17/11/2023 | By Manvi | 807
Clean Label Project Certifies Visbiome GI Care High Potency Capsules
Visbiome GI Care High Potency Capsules underwent the Clean Label Project's rigorous testing process.
Global Pharma | 17/11/2023 | By Manvi | 693
Granules India Q2FY24 Revenue from Operations Stood at INR 11,895 Million up 3 percent YoY
Volume growth YoY was higher as compared to the value growth.
Global Pharma | 17/11/2023 | By Manvi | 751
INTEGRA Biosciences Releases New eBook
INTEGRA Biosciences announce the release of a new eBook providing a complete guide to pipetting.
Global Pharma | 09/11/2023 | By Manvi | 705
Lupin launches Rocuronium Bromide Injection in US
Lupin announced the launch of Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL) Multiple-Dose Vials, after Lupin’s alliance partner Caplin Steriles Limited (Caplin) received approval for its ANDA from the United States Food and Drug Administration (US FDA).
Global Pharma | 09/11/2023 | By Manvi | 276
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy